Lattice Biologics Ltd. (LBLTF)

Market Cap	128.00
Revenue (ttm)	1.56M -28.9%
Net Income	-951.65K
EPS	-0.01
Shares Out	128.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.000001
Beta	1.25
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Lattice Biologics

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization,...

• Industry: Medical Devices
• Sector: Healthcare
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: LBLTF

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 20, 2026

Data Sources Report a data error